<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT03044145</url>
  </required_header>
  <id_info>
    <org_study_id>7234</org_study_id>
    <secondary_id>1K23MH102334</secondary_id>
    <nct_id>NCT03044145</nct_id>
  </id_info>
  <brief_title>The Cultural Formulation Interview-Engagement Aid</brief_title>
  <acronym>CFI-EA</acronym>
  <official_title>The Cultural Formulation Interview-Engagement Aid for Mental Health Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York State Psychiatric Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>New York State Psychiatric Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study consists of two projects:&#xD;
&#xD;
      Project 1: The study team will create and refine the CFI-EA by enrolling 3 clinicians and&#xD;
      9-12 patients to test the CFI-EA's feasibility and acceptability from patient and clinician&#xD;
      feedback in a pre-pilot trial. The study team will first train clinicians in the CFI-EA by&#xD;
      reading over the CFI-EA treatment manual and practicing how they can use it in behavioral&#xD;
      simulations, and then check whether participants think they can do it (feasibility) and like&#xD;
      it (acceptability) through standard measures. Following this the study team will revise the&#xD;
      CFI-EA based on their feedback for the comparative open trial in Phase 2.&#xD;
&#xD;
      Project 2: The study team will test the revised CFI-EA against treatment as usual in a pilot&#xD;
      trial. 3 clinicians and 12-15 patients will be enrolled in each arm. As before, the study&#xD;
      team will first train clinicians in the revised CFI-EA by reading over the CFI-EA treatment&#xD;
      manual and practicing how they can use it in behavioral simulations. Then, the study team&#xD;
      will check whether participants think they can do it (feasibility) and like it&#xD;
      (acceptability) through standard measures, and in addition will also explore any initial&#xD;
      effects on communication behaviors among patients and clinicians and treatment engagement&#xD;
      based on treatment retention.&#xD;
&#xD;
      The specific aims are:&#xD;
&#xD;
      For Project 1:&#xD;
&#xD;
        1. To pretest the CFI-EA intervention in a mental health setting through a pre-pilot open&#xD;
           trial that explores communication mechanisms of action in terms of communication&#xD;
           behavior and cultural content, and&#xD;
&#xD;
        2. To revise the CFI-EA intervention based on patient and clinician feedback on its&#xD;
           feasibility and acceptability.&#xD;
&#xD;
      As real-world community stakeholders for whom the CFI-EA is being developed, patients and&#xD;
      clinicians can provide helpful perspectives on how the CFI-EA can help clinicians tailor&#xD;
      treatment plans around patient cultural views and treatment preferences to keep patients in&#xD;
      care. The CFI-EA will be revised around areas of maximal agreement among patients and&#xD;
      clinicians with the help of health disparities and communication experts.&#xD;
&#xD;
      For Project 2:&#xD;
&#xD;
        1. To test the revised CFI-EA's feasibility and acceptability among patients and clinicians&#xD;
           in a pilot open trial against treatment as usual, and&#xD;
&#xD;
        2. To explore the relationship between the revised CFI-EA's effects on patient-clinician&#xD;
           communication and treatment engagement.&#xD;
&#xD;
      The study team hypothesize that clinicians using the revised CFI-EA will show more positive&#xD;
      communication behaviors compared to clinicians delivering treatment as usual and that CFI-EA&#xD;
      patients will stay in treatment longer. Communication behaviors will be assessed through&#xD;
      communication analysis techniques such as the Roter Interaction Analysis System.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Members of underserved racial/ethnic minority groups who participate more actively in the&#xD;
      treatment process have almost three times the odds of staying in treatment and following up&#xD;
      with appointments compared to standard treatment. Improving patient-clinician communication&#xD;
      may therefore improve treatment engagement, from starting and participating in treatment&#xD;
      actively to maintaining treatment for the successful resolution of symptoms and improvements&#xD;
      in quality of life. Interventions that enhance communication behaviors by asking patients&#xD;
      about their cultural views, using open-ended questions, establishing rapport, and using&#xD;
      patient terms can increase patient participation and satisfaction. Interventions that expose&#xD;
      clinicians to cultural content by asking patients about preferences for treatment, barriers&#xD;
      to accessing services, the role of support from family or friends, and that encourage&#xD;
      information exchange also improve treatment engagement. The goal of this study is to develop&#xD;
      a communication intervention that improves treatment engagement for members of underserved&#xD;
      racial and ethnic minority groups by improving clinician communication behaviors and exposing&#xD;
      them to patient cultural content. Here, culture is understood as a dynamic process of meaning&#xD;
      making between the patient and clinician. This intervention is not designed for patients&#xD;
      belonging to a specific racial or ethnic group, but to improve general communication between&#xD;
      patients and clinicians. The intervention improves communication by making communication&#xD;
      behaviors and cultural content topics of explicit conversation rather than allowing&#xD;
      clinicians to make cultural assumptions and take them for granted. We are focusing on racial&#xD;
      and ethnic minorities because of significant evidence documenting disparities in health&#xD;
      communication and care.&#xD;
&#xD;
      In session 1, the clinician does the full CFI in DSM-5 (~15 minutes) and then completes the&#xD;
      full standard intake with information not already obtained through the CFI (~35 minutes). In&#xD;
      sessions 2 and 3, the clinician integrates the CFI-EA (~5 minutes) within regular care in&#xD;
      standard appointments. At JHMC, Session 2 lasts 60 minutes and is for treatment initiation.&#xD;
      Session 3 lasts 20-30 minutes and is to check for treatment continuation. Because this is a&#xD;
      grant to train in developing mental health interventions, the study team is following an NIMH&#xD;
      model known as the Stage Model of Intervention Development. The first project is creating the&#xD;
      intervention through patient and clinician feedback at JHMC and expert consensus with the K23&#xD;
      mentoring team. The second project is testing the intervention in a trial that compares the&#xD;
      CFI-EA to treatment as usual. Patients for Project 1 will be recruited through a sample of&#xD;
      convenience among patients accessing care on the days the research assistant is in the&#xD;
      waiting area. For project 2, patients will be sampled consecutively by the JHMC's intake&#xD;
      coordinator from the time that the project starts until the target enrollment is reached. The&#xD;
      intake coordinator will keep a record of all patients who agree and do not agree to enroll in&#xD;
      the study. Patients who agree to be enrolled during Project 2 will be recruited by the&#xD;
      research assistant in the waiting area and then assigned randomly to either CFI-EA clinicians&#xD;
      or treatment-as-usual clinicians based on a random number generator. The study team is using&#xD;
      the same study measures in both projects to examine whether revisions to the CFI-EA conducted&#xD;
      at the end of Project 1 show improvements in outcomes after Project 2.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 20, 2016</start_date>
  <completion_date type="Actual">September 5, 2018</completion_date>
  <primary_completion_date type="Actual">September 5, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>This study follows an NIMH model known as the Stage Model of Intervention Development. The first project is creating a cross-cultural communication intervention designed to improve patient adherence in mental health services through patient and clinician feedback at JHMC and expert consensus with my K23 mentoring team. The second project is testing the intervention in a trial that compares the CFI-EA to treatment as usual.</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CFI-EA feasibility is defined as patient completion rates for all three sessions of the CFI-EA intervention.</measure>
    <time_frame>two months after the third session</time_frame>
    <description>CFI-EA feasibility is defined as patient completion rates for all three sessions of the CFI-EA intervention.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>CFI-EA acceptability is defined as patient scores on the CSQ-8.</measure>
    <time_frame>the third session</time_frame>
    <description>CFI-EA acceptability is defined as patient scores on the CSQ-8.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment engagement defined as the percentage of patients staying within treatment 2 months after the third and last session of the CFI-EA has been delivered.</measure>
    <time_frame>2 months after the last session of the CFI-EA</time_frame>
    <description>Defined as the percentage of patients staying within treatment 2 months after the third and last session of the CFI-EA has been delivered.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Communication</condition>
  <condition>Adherence, Patient</condition>
  <arm_group>
    <arm_group_label>Project 1: The Cultural Formulation Interview-Engagement Aid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The first project is creating the intervention through patient and clinician feedback at JHMC and expert consensus with the K23 mentoring team. The CFI-EA is a list of questions that clinicians can use to customize patient treatment plans based on a cultural competence assessment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Project 2: The Cultural Formulation Interview-Engagement Aid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this arm the study team will test the revised CFI-EA against treatment as usual in a pilot trial.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Project 2: Treatment as usual</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment as usual at JHMC consists of clinicians creating treatment plans for patients without any specific training in medical communication or treatment negotiation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>The Cultural Formulation Interview-Engagement Aid</intervention_name>
    <description>Culture affects how all people communicate and understand the world. Culture is important because patients and clinicians from different cultural backgrounds may have different preferences for communication. Mismatch in the clinician's approach and the patient's expectations of care can lead to patient dissatisfaction and discontinuation with treatment. Patients and clinicians may also have different views about what caused an illness, how it functions, what makes it better or worse, and the types of treatment needed. The CFI-EA is a series of questions over three sessions that clinicians can use to clarify patient views about treatment and communication so that patients stay in treatment longer. Clinicians can use the CFI-EA to customize their current treatment plans.</description>
    <arm_group_label>Project 1: The Cultural Formulation Interview-Engagement Aid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>The Cultural Formulation Interview-Engagement Aid (Revised)</intervention_name>
    <description>The study team will revise the CFI-EA based on patient and clinician feedback. The study team expects that the revisions will consist of changes to the questions such as adding or subtracting specific items or revising the wording of the content. The study team do not anticipate other changes, though we will let our empirical data analyses guide revisions in consultation with the K23 mentor team.</description>
    <arm_group_label>Project 2: The Cultural Formulation Interview-Engagement Aid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Treatment as usual</intervention_name>
    <description>Standard mental health treatment at FHMC</description>
    <arm_group_label>Project 2: Treatment as usual</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        For Project 1&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Male and female patients aged 18-80; Method of ascertainment: Self-report.&#xD;
&#xD;
          -  New patients at JHMC, referred by the intake coordinator; Method of ascertainment:&#xD;
             Intake coordinator.&#xD;
&#xD;
          -  Willingness and ability to provide written informed consent after full explanation of&#xD;
             study procedures. Method of ascertainment: RA informed consent interview that includes&#xD;
             a capacity to consent screening form; Clinician referral.&#xD;
&#xD;
          -  Racial and ethnic minority (African-American, Latino/Hispanic, Asian-American/Pacific&#xD;
             Islander, and Native American). Method of ascertainment: Self-report&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Actively suicidal or homicidal; Method of ascertainment: Self-report and clinician&#xD;
             evaluation&#xD;
&#xD;
          -  In need of acute detoxification services; Method of ascertainment: Self-report and&#xD;
             clinician evaluation&#xD;
&#xD;
          -  A condition that interferes with participation (i.e., dementia, mental retardation, or&#xD;
             florid psychosis); Method of ascertainment: Clinician evaluation; patients ≥ 65 years&#xD;
             of age will participate in a mini-cog exam.&#xD;
&#xD;
          -  Caucasian race; Method of ascertainment: self-report&#xD;
&#xD;
        For Project 2&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Male and female patients aged 18-80; Method of ascertainment: Self-report.&#xD;
&#xD;
          -  New patients at JHMC, referred by the intake coordinator; Method of ascertainment:&#xD;
             Intake coordinator.&#xD;
&#xD;
          -  Willingness and ability to provide written informed consent after full explanation of&#xD;
             study procedures. Method of ascertainment: RA informed consent interview that includes&#xD;
             a capacity to consent screening form; Clinician referral.&#xD;
&#xD;
          -  Racial and ethnic minority (African-American, Latino/Hispanic, Asian-American/Pacific&#xD;
             Islander, and Native American). Method of ascertainment: Self-report&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Actively suicidal or homicidal; Method of ascertainment: Self-report and clinician&#xD;
             evaluation&#xD;
&#xD;
          -  In need of acute detoxification services; Method of ascertainment: Self-report and&#xD;
             clinician evaluation&#xD;
&#xD;
          -  A condition that interferes with participation (i.e., dementia, mental retardation, or&#xD;
             florid psychosis); Method of ascertainment: Clinician evaluation; patients ≥ 65 years&#xD;
             of age will participate in a mini-cog exam.&#xD;
&#xD;
          -  Caucasian race; Method of ascertainment: self-report&#xD;
&#xD;
          -  Patients in Project 1 will be excluded from Participation in Project 2: Method of&#xD;
             assessment: self-report and PI/RA evaluation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neil K Aggarwal, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York State Psychiatric Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Flushing Hospital Medical Center</name>
      <address>
        <city>Flushing</city>
        <state>New York</state>
        <zip>11355</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>January 30, 2017</study_first_submitted>
  <study_first_submitted_qc>February 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 6, 2017</study_first_posted>
  <last_update_submitted>January 24, 2019</last_update_submitted>
  <last_update_submitted_qc>January 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>New York State Psychiatric Institute</investigator_affiliation>
    <investigator_full_name>Neil Krishan Aggarwal</investigator_full_name>
    <investigator_title>Research Psychiatrist</investigator_title>
  </responsible_party>
  <keyword>Cultural Competence</keyword>
  <keyword>Patient-Clinician communication</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>


download date: ClinicalTrials.gov processed this data on September 20, 2023
link text: Link to the current ClinicalTrials.gov record.
url: https://clinicaltrials.gov/ct2/show/NCT03044145
org study id: 7234
secondary id: 1K23MH102334
nct id: NCT03044145
lead sponsor: 
collaborator: 
has dmc: No
is fda regulated drug: No
is fda regulated device: No
This study consists of two projects:

      Project 1: The study team will create and refine the CFI-EA by enrolling 3 clinicians and
      9-12 patients to test the CFI-EA's feasibility and acceptability from patient and clinician
      feedback in a pre-pilot trial. The study team will first train clinicians in the CFI-EA by
      reading over the CFI-EA treatment manual and practicing how they can use it in behavioral
      simulations, and then check whether participants think they can do it (feasibility) and like
      it (acceptability) through standard measures. Following this the study team will revise the
      CFI-EA based on their feedback for the comparative open trial in Phase 2.

      Project 2: The study team will test the revised CFI-EA against treatment as usual in a pilot
      trial. 3 clinicians and 12-15 patients will be enrolled in each arm. As before, the study
      team will first train clinicians in the revised CFI-EA by reading over the CFI-EA treatment
      manual and practicing how they can use it in behavioral simulations. Then, the study team
      will check whether participants think they can do it (feasibility) and like it
      (acceptability) through standard measures, and in addition will also explore any initial
      effects on communication behaviors among patients and clinicians and treatment engagement
      based on treatment retention.

      The specific aims are:

      For Project 1:

        1. To pretest the CFI-EA intervention in a mental health setting through a pre-pilot open
           trial that explores communication mechanisms of action in terms of communication
           behavior and cultural content, and

        2. To revise the CFI-EA intervention based on patient and clinician feedback on its
           feasibility and acceptability.

      As real-world community stakeholders for whom the CFI-EA is being developed, patients and
      clinicians can provide helpful perspectives on how the CFI-EA can help clinicians tailor
      treatment plans around patient cultural views and treatment preferences to keep patients in
      care. The CFI-EA will be revised around areas of maximal agreement among patients and
      clinicians with the help of health disparities and communication experts.

      For Project 2:

        1. To test the revised CFI-EA's feasibility and acceptability among patients and clinicians
           in a pilot open trial against treatment as usual, and

        2. To explore the relationship between the revised CFI-EA's effects on patient-clinician
           communication and treatment engagement.

      The study team hypothesize that clinicians using the revised CFI-EA will show more positive
      communication behaviors compared to clinicians delivering treatment as usual and that CFI-EA
      patients will stay in treatment longer. Communication behaviors will be assessed through
      communication analysis techniques such as the Roter Interaction Analysis System.
Members of underserved racial/ethnic minority groups who participate more actively in the
      treatment process have almost three times the odds of staying in treatment and following up
      with appointments compared to standard treatment. Improving patient-clinician communication
      may therefore improve treatment engagement, from starting and participating in treatment
      actively to maintaining treatment for the successful resolution of symptoms and improvements
      in quality of life. Interventions that enhance communication behaviors by asking patients
      about their cultural views, using open-ended questions, establishing rapport, and using
      patient terms can increase patient participation and satisfaction. Interventions that expose
      clinicians to cultural content by asking patients about preferences for treatment, barriers
      to accessing services, the role of support from family or friends, and that encourage
      information exchange also improve treatment engagement. The goal of this study is to develop
      a communication intervention that improves treatment engagement for members of underserved
      racial and ethnic minority groups by improving clinician communication behaviors and exposing
      them to patient cultural content. Here, culture is understood as a dynamic process of meaning
      making between the patient and clinician. This intervention is not designed for patients
      belonging to a specific racial or ethnic group, but to improve general communication between
      patients and clinicians. The intervention improves communication by making communication
      behaviors and cultural content topics of explicit conversation rather than allowing
      clinicians to make cultural assumptions and take them for granted. We are focusing on racial
      and ethnic minorities because of significant evidence documenting disparities in health
      communication and care.

      In session 1, the clinician does the full CFI in DSM-5 (~15 minutes) and then completes the
      full standard intake with information not already obtained through the CFI (~35 minutes). In
      sessions 2 and 3, the clinician integrates the CFI-EA (~5 minutes) within regular care in
      standard appointments. At JHMC, Session 2 lasts 60 minutes and is for treatment initiation.
      Session 3 lasts 20-30 minutes and is to check for treatment continuation. Because this is a
      grant to train in developing mental health interventions, the study team is following an NIMH
      model known as the Stage Model of Intervention Development. The first project is creating the
      intervention through patient and clinician feedback at JHMC and expert consensus with the K23
      mentoring team. The second project is testing the intervention in a trial that compares the
      CFI-EA to treatment as usual. Patients for Project 1 will be recruited through a sample of
      convenience among patients accessing care on the days the research assistant is in the
      waiting area. For project 2, patients will be sampled consecutively by the JHMC's intake
      coordinator from the time that the project starts until the target enrollment is reached. The
      intake coordinator will keep a record of all patients who agree and do not agree to enroll in
      the study. Patients who agree to be enrolled during Project 2 will be recruited by the
      research assistant in the waiting area and then assigned randomly to either CFI-EA clinicians
      or treatment-as-usual clinicians based on a random number generator. The study team is using
      the same study measures in both projects to examine whether revisions to the CFI-EA conducted
      at the end of Project 1 show improvements in outcomes after Project 2.
allocation: Randomized
intervention model: Sequential Assignment
intervention model description: This study follows an NIMH model known as the Stage Model of Intervention Development. The first project is creating a cross-cultural communication intervention designed to improve patient adherence in mental health services through patient and clinician feedback at JHMC and expert consensus with my K23 mentoring team. The second project is testing the intervention in a trial that compares the CFI-EA to treatment as usual.
primary purpose: Health Services Research
masking: Single (Participant)
measure: CFI-EA feasibility is defined as patient completion rates for all three sessions of the CFI-EA intervention.
time frame: two months after the third session
description: CFI-EA feasibility is defined as patient completion rates for all three sessions of the CFI-EA intervention.
measure: CFI-EA acceptability is defined as patient scores on the CSQ-8.
time frame: the third session
description: CFI-EA acceptability is defined as patient scores on the CSQ-8.
measure: Treatment engagement defined as the percentage of patients staying within treatment 2 months after the third and last session of the CFI-EA has been delivered.
time frame: 2 months after the last session of the CFI-EA
description: Defined as the percentage of patients staying within treatment 2 months after the third and last session of the CFI-EA has been delivered.
arm group label: Project 1: The Cultural Formulation Interview-Engagement Aid
arm group type: Experimental
description: The first project is creating the intervention through patient and clinician feedback at JHMC and expert consensus with the K23 mentoring team. The CFI-EA is a list of questions that clinicians can use to customize patient treatment plans based on a cultural competence assessment.
arm group label: Project 2: The Cultural Formulation Interview-Engagement Aid
arm group type: Experimental
description: In this arm the study team will test the revised CFI-EA against treatment as usual in a pilot trial.
arm group label: Project 2: Treatment as usual
arm group type: Active Comparator
description: Treatment as usual at JHMC consists of clinicians creating treatment plans for patients without any specific training in medical communication or treatment negotiation.
intervention type: Behavioral
intervention name: The Cultural Formulation Interview-Engagement Aid
description: Culture affects how all people communicate and understand the world. Culture is important because patients and clinicians from different cultural backgrounds may have different preferences for communication. Mismatch in the clinician's approach and the patient's expectations of care can lead to patient dissatisfaction and discontinuation with treatment. Patients and clinicians may also have different views about what caused an illness, how it functions, what makes it better or worse, and the types of treatment needed. The CFI-EA is a series of questions over three sessions that clinicians can use to clarify patient views about treatment and communication so that patients stay in treatment longer. Clinicians can use the CFI-EA to customize their current treatment plans.
arm group label: Project 1: The Cultural Formulation Interview-Engagement Aid
intervention type: Behavioral
intervention name: The Cultural Formulation Interview-Engagement Aid (Revised)
description: The study team will revise the CFI-EA based on patient and clinician feedback. The study team expects that the revisions will consist of changes to the questions such as adding or subtracting specific items or revising the wording of the content. The study team do not anticipate other changes, though we will let our empirical data analyses guide revisions in consultation with the K23 mentor team.
arm group label: Project 2: The Cultural Formulation Interview-Engagement Aid
intervention type: Behavioral
intervention name: Treatment as usual
description: Standard mental health treatment at FHMC
arm group label: Project 2: Treatment as usual
criteria: 
gender: All
minimum age: 18 Years
maximum age: 80 Years
healthy volunteers: No
last name: Neil K Aggarwal, M.D.
role: Principal Investigator
affiliation: New York State Psychiatric Institute
facility: 
country: United States
responsible party type: Principal Investigator
investigator affiliation: New York State Psychiatric Institute
investigator full name: Neil Krishan Aggarwal
investigator title: Research Psychiatrist
sharing ipd: No